Amgen projects 2026 revenue of $38. 9B-$39. 7B while raising non-GAAP EPS to $22. 90-$23. 70

The development centers on amgen projects 2026 revenue of $38.9B-$39.7B while raising non-GAAP EPS to $22.90-$23.70.